BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 20188661)

  • 1. Taking MLL through the MudPIT: identification of novel complexes that bring together MLL-fusion proteins and transcription elongation factors.
    Fromm G; Adelman K
    Mol Cell; 2010 Feb; 37(4):449-50. PubMed ID: 20188661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Misguided transcriptional elongation causes mixed lineage leukemia.
    Mueller D; García-Cuéllar MP; Bach C; Buhl S; Maethner E; Slany RK
    PLoS Biol; 2009 Nov; 7(11):e1000249. PubMed ID: 19956800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cooperative gene activation by AF4 and DOT1L drives MLL-rearranged leukemia.
    Okuda H; Stanojevic B; Kanai A; Kawamura T; Takahashi S; Matsui H; Takaori-Kondo A; Yokoyama A
    J Clin Invest; 2017 May; 127(5):1918-1931. PubMed ID: 28394257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AFF4, a component of the ELL/P-TEFb elongation complex and a shared subunit of MLL chimeras, can link transcription elongation to leukemia.
    Lin C; Smith ER; Takahashi H; Lai KC; Martin-Brown S; Florens L; Washburn MP; Conaway JW; Conaway RC; Shilatifard A
    Mol Cell; 2010 Feb; 37(3):429-37. PubMed ID: 20159561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Function of leukemogenic mixed lineage leukemia 1 (MLL) fusion proteins through distinct partner protein complexes.
    Biswas D; Milne TA; Basrur V; Kim J; Elenitoba-Johnson KS; Allis CD; Roeder RG
    Proc Natl Acad Sci U S A; 2011 Sep; 108(38):15751-6. PubMed ID: 21896721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The super elongation complex (SEC) and MLL in development and disease.
    Smith E; Lin C; Shilatifard A
    Genes Dev; 2011 Apr; 25(7):661-72. PubMed ID: 21460034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptional activation by MLL fusion proteins in leukemogenesis.
    Yokoyama A
    Exp Hematol; 2017 Feb; 46():21-30. PubMed ID: 27865805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MLL-ENL inhibits polycomb repressive complex 1 to achieve efficient transformation of hematopoietic cells.
    Maethner E; Garcia-Cuellar MP; Breitinger C; Takacova S; Divoky V; Hess JL; Slany RK
    Cell Rep; 2013 May; 3(5):1553-66. PubMed ID: 23623499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AF4 and AF4-MLL mediate transcriptional elongation of 5-lipoxygenase mRNA by 1, 25-dihydroxyvitamin D3.
    Ahmad K; Scholz B; Capelo R; Schweighöfer I; Kahnt AS; Marschalek R; Steinhilber D
    Oncotarget; 2015 Sep; 6(28):25784-800. PubMed ID: 26329759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An AF9/ENL-targted peptide with therapeutic potential in mixed lineage leukemias.
    Barretto NN; Karahalios DS; You D; Hemenway CS
    J Exp Ther Oncol; 2014; 10(4):293-300. PubMed ID: 25509985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The super elongation complex (SEC) family in transcriptional control.
    Luo Z; Lin C; Shilatifard A
    Nat Rev Mol Cell Biol; 2012 Sep; 13(9):543-7. PubMed ID: 22895430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcription control by the ENL YEATS domain in acute leukaemia.
    Erb MA; Scott TG; Li BE; Xie H; Paulk J; Seo HS; Souza A; Roberts JM; Dastjerdi S; Buckley DL; Sanjana NE; Shalem O; Nabet B; Zeid R; Offei-Addo NK; Dhe-Paganon S; Zhang F; Orkin SH; Winter GE; Bradner JE
    Nature; 2017 Mar; 543(7644):270-274. PubMed ID: 28241139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leukemogenesis via aberrant self-renewal by the MLL/AEP-mediated transcriptional activation system.
    Yokoyama A
    Cancer Sci; 2021 Oct; 112(10):3935-3944. PubMed ID: 34251718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Turning on a dimer: new insights into MLL chimeras.
    Hsu K; Look AT
    Cancer Cell; 2003 Aug; 4(2):81-3. PubMed ID: 12957280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human Polymerase-Associated Factor complex (PAFc) connects the Super Elongation Complex (SEC) to RNA polymerase II on chromatin.
    He N; Chan CK; Sobhian B; Chou S; Xue Y; Liu M; Alber T; Benkirane M; Zhou Q
    Proc Natl Acad Sci U S A; 2011 Sep; 108(36):E636-45. PubMed ID: 21873227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A higher-order complex containing AF4 and ENL family proteins with P-TEFb facilitates oncogenic and physiologic MLL-dependent transcription.
    Yokoyama A; Lin M; Naresh A; Kitabayashi I; Cleary ML
    Cancer Cell; 2010 Feb; 17(2):198-212. PubMed ID: 20153263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The elongation domain of ELL is dispensable but its ELL-associated factor 1 interaction domain is essential for MLL-ELL-induced leukemogenesis.
    Luo RT; Lavau C; Du C; Simone F; Polak PE; Kawamata S; Thirman MJ
    Mol Cell Biol; 2001 Aug; 21(16):5678-87. PubMed ID: 11463848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Keeping RNA polymerase II on the run: Functions of MLL fusion partners in transcriptional regulation.
    Basu S; Nandy A; Biswas D
    Biochim Biophys Acta Gene Regul Mech; 2020 Aug; 1863(8):194563. PubMed ID: 32348849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Authors' comments: t(4;11) leukemias display addiction to MLL-AF4 but not to AF4-MLL.
    Kumar AR; Yao Q; Li Q; Sam TA; Kersey JH
    Leuk Res; 2011 May; 35(5):697. PubMed ID: 21277021
    [No Abstract]   [Full Text] [Related]  

  • 20. Interaction of AF4 wild-type and AF4.MLL fusion protein with SIAH proteins: indication for t(4;11) pathobiology?
    Bursen A; Moritz S; Gaussmann A; Moritz S; Dingermann T; Marschalek R
    Oncogene; 2004 Aug; 23(37):6237-49. PubMed ID: 15221006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.